73
Peptide profiles
75
Compounds compared
258
Verified discount codes
100%
Independent research
4,362
Prices compared
Certificates lab-checked in the last 7 days, as of November 22, 2026: NexPept, SPX Labs, Inno Aminos and 2 more.
Prof. Peptide provides peptide research for educational purposes only. Nothing on this site constitutes medical advice or endorses human use of research peptides.
Everything a researcher needs
From peptide mechanisms to reconstitution math — Prof. Peptide covers it all, clearly and credibly.
Peptide Library
Comprehensive profiles on 73 research peptides — mechanisms, half-lives, stacking protocols, and more.
Browse library →Bioregulator Guide
A research guide to the Khavinson short-peptide bioregulators — the gene-regulation hypothesis, synthetic analogs vs. organ extracts, and the individual compounds.
Read the guide →Comparisons
Side-by-side breakdowns of popular peptides and supplements — mechanisms, evidence, dosing, and how to choose between them.
Compare compounds →Featured Vendors
The vetted alphabetical list of research peptide suppliers — with third-party testing, published COAs, and the quality criteria Prof. Peptide uses to include them.
See vetted vendors →Prices
Compare research-peptide prices across 258 vendors — normalized to $/mg by vial size, post-code, and sorted lowest-first.
Compare prices →Coupon Codes
Verified discount codes for research-grade suppliers. Updated regularly.
See codes →Peptide Reconstitution & Dosage Calculator
Accurately reconstitute and dose any peptide with our step-by-step research calculator.
Open calculator →Get the App
The all-in-one peptide tracker for iPhone — log doses, see estimated levels, run protocols, and search 70+ peptides by name or brand.
Download →News
The latest peptide research news, regulatory updates, and developments.
View news →Latest News
View all newsNovember 22, 2026
Eloralintide Plus Tirzepatide (EloraTZP): 23.3% Weight Loss vs 14.8% on Tirzepatide Alone in Phase 2
Lilly's phase 2b trial of EloraTZP (eloralintide, an investigational amylin agonist, with tirzepatide) in 367 adults with obesity or overweight and type 2 diabetes: up to 23.3% weight loss at 48 weeks (eloralintide 9 mg + tirzepatide 15 mg) vs 14.8% on tirzepatide 15 mg and 3.0% on placebo, with more GI side effects and 10.8% to 27.0% stopping for adverse events on the combination. Company-reported; new participant reports at ObesityWeek.
Read more →November 22, 2026
Australia's TGA Tests Seized KLOW, BPC-157/TB-500 and Retatrutide Vials: No TB-500 Found
The TGA's November 5, 2026 advisory: its laboratory found no detectable TB-500 in Synedica "KLOW 80 mg", "BARBIE KLOW 100 mg" and "BPC 157 & TB 500 10 mg", and less retatrutide than labeled in Synedica "Retatrutide 10 mg", with significant variation between samples. The findings cover the tested Synedica products, seized with NSW Police.
Read more →November 19, 2026
Thymosin Beta-4 Eye Drop RGN-259 Misses Its Primary Endpoint in a Third Phase 3 Trial
SEER-2, a phase 3 trial of RGN-259 (thymosin beta-4 eye drops) for neurotrophic keratopathy at 50 sites, did not reach statistical significance on complete healing at 4 weeks, its sponsor reported in November 2026; no rates are published yet. None of the eye drop's three phase 3 trials has met its primary endpoint, and the results say nothing about injected TB-500.
Read more →Built for researchers
Most peptide sites exist to sell products. Prof. Peptide exists to educate. We're independent, ad-light, and committed to presenting research accurately — including limitations and unknowns.
- ✓Content is editorially independent and research-driven
- ✓Every peptide profile cites primary research literature
- ✓Calculator math is transparent and peer-reviewable
- ✓Discount codes are manually verified before publishing
Now on iOS
The all-in-one peptide tracker
Log doses, see estimated levels, calculate reconstitution, and search 70+ peptides by name or brand — all in one private iOS app.
Get the AppDon't overpay for peptides.
Prof. Peptide finds the best deals and delivers them to your inbox.

